
### [NCIT:C9295](http://purl.obolibrary.org/obo/NCIT_C9295)
**Label:** Mast Cell Neoplasm

**Subclasses:** [NCIT:C3169](http://purl.obolibrary.org/obo/NCIT_C3169) (Mast Cell Leukemia), [NCIT:C3217](http://purl.obolibrary.org/obo/NCIT_C3217) (Benign Mastocytoma), [NCIT:C43284](http://purl.obolibrary.org/obo/NCIT_C43284) (Primary Systemic Mastocytosis), [NCIT:C9303](http://purl.obolibrary.org/obo/NCIT_C9303) (Mastocytoma), [NCIT:C9348](http://purl.obolibrary.org/obo/NCIT_C9348) (Mast Cell Sarcoma), [NCIT:C84269](http://purl.obolibrary.org/obo/NCIT_C84269) (Mastocytosis), [NCIT:C7137](http://purl.obolibrary.org/obo/NCIT_C7137) (Cutaneous Mastocytosis), [NCIT:C43277](http://purl.obolibrary.org/obo/NCIT_C43277) (Pure Cutaneous Mastocytosis), [NCIT:C9235](http://purl.obolibrary.org/obo/NCIT_C9235) (Systemic Mastocytosis), [NCIT:C7136](http://purl.obolibrary.org/obo/NCIT_C7136) (Extracutaneous Mastocytoma), [NCIT:C8991](http://purl.obolibrary.org/obo/NCIT_C8991) (Malignant Mastocytosis), [NCIT:C9286](http://purl.obolibrary.org/obo/NCIT_C9286) (Indolent Systemic Mastocytosis), [NCIT:C9284](http://purl.obolibrary.org/obo/NCIT_C9284) (Systemic Mastocytosis with an Associated Hematological Neoplasm (SM-AHN)), [NCIT:C9285](http://purl.obolibrary.org/obo/NCIT_C9285) (Aggressive Systemic Mastocytosis), 

**Class expressions from DL-Learner:**

- Thing 52.12%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 42.50%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 42.50%


